glp 1 inflammatory bowel disease The alleviating effect and mechanism of GLP-1 on ulcerative colitis The anti-inflammatory and immunological properties
Description
Weight loss was the main reason cited by those taking or considering GLP1s (58%), ahead of diabetes (42%) and heart health (22%)

Insurance Medical insurance policies typically do not cover weight management care and related expenses, including laboratory testing, electrocardiograms, prescription medication and related supplements

While proponents claim that using lower doses can reduce side effects, there is a lack of scientific evidence to support this

GLP-1 drug prescriptions are expensive

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

WHO Publ
